Swann Alan C
Dr. Swann is the Pat R. Rutherford, Jr., Professor and Vice Chair for Research, Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School in Houston, Texas.
Psychiatry (Edgmont). 2006 Jun;3(6):40-2.
This is a commentary on Hippocratic Psychopharmacology in Bipolar Disorder, an article by S. Nasir Ghaemi in this issue of Psychiatry 2006.
Based on Dr. Ghaemi's article and relevant literature, I discuss implications of Hippocratic treatment, i.e., the principle of treating an underlying illness using methods that enhance the patient's adaptive responses, rather than using symptomatic treatments.
Key points include 1) the course of illness, as heterogeneous as it is, seems to have episodic-stable and inherently unstable forms; 2) course of illness interacts with episode characteristics, with mixed or polyphasic episodes associated with an unstable and complicated course of illness; 3) consequences in terms of treatment response, with lithium being more effective in treating the episodic-stable than the unstable form of the illness; and 4) the fact that, in determining treatment response, course of illness trumps episode characteristics. The goal of Hippocratic/Oslerian medicine, curative treatment aimed at underlying mechanisms of disease, is the aim of treatment, but is still elusive.
这是对《双相情感障碍中的希波克拉底精神药理学》的一篇评论,该文章由S.纳西尔·加米撰写,发表于本期《精神病学》2006年。
基于加米博士的文章及相关文献,我探讨了希波克拉底式治疗的意义,即采用增强患者适应性反应的方法治疗潜在疾病,而非对症治疗的原则。
要点包括:1)疾病进程虽具有异质性,但似乎有发作性稳定和内在不稳定两种形式;2)疾病进程与发作特征相互作用,混合或多相发作与不稳定且复杂的疾病进程相关;3)治疗反应方面的结果,锂盐在治疗发作性稳定型疾病比不稳定型疾病更有效;4)在确定治疗反应时,疾病进程比发作特征更重要这一事实。希波克拉底/奥斯勒式医学的目标,即针对疾病潜在机制的治愈性治疗,是治疗的目标,但仍难以实现。